Mechanisms underlying the cytotoxicity of a novel quinazolinedione‐based redox modulator, <scp>QD</scp>232, in pancreatic cancer cells
Divya Pathania(AbbVie (United States)), Nouri Neamati(Michigan Medicine)
Cited by 9
Related Papers
Current Challenges and Opportunities in Treating Glioblastoma
|Pharmacological Reviews|2018|888
Integrated Magneto–Electrochemical Sensor for Exosome Analysis
|ACS Nano|2016|474
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
|Nature Communications|2023|84
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
|Nature Communications|2016|74